Dissertation > Excellent graduate degree dissertation topics show

ABCG2 Expression and the Study of Methylaion in Gleevec-resistant Chronic Myeloid Leukemia Cell Line

Author: HuRunHong
Tutor: ChenFangPing
School: Central South University
Course: Internal Medicine
Keywords: Chronic myeloid leukemia (CML) Gleevec breast cancer resistance protein (BCRP/ABCG2) methylation
CLC: R733.7
Type: Master's thesis
Year: 2011
Downloads: 30
Quote: 0
Read: Download Dissertation

Abstract


BACKGROUD AND OBJECTIVE:Chronic myeloid leukemia (CML) is a clonal proliferative disease, with self-renewing populations of the stem and progenitor cell, the characteristic cytogenetic abnormality underlying CML is the Philadelphia chromosome (Ph) [t (9; 22) (q34; q11)], which cause the Abelson tk gene(ABL) to fuse with the breakpoint cluster region of the BCR gene. The BCR/ABL fusion protein has sustained tyrosine kinase activity, is the key factor in the pathogenesis of CML. Gleevec is widely recognized as a small molecule drugs of ideal targeted treatment for CML. But Gleevec resistance have seriously affected the treatment of CML, it is urgent to resolve this problem. Alough Gleevec resistance is mainly mediated by BCR/ALB, but some researches has shown that the membrane transporters also have close relationship with it. Studies have found that the breast cancer resistance protein (BCRP/ABCG2), a member of ATP binding cassette (ABC) transporter superfamily, may led to resistance to Gleevec. In the ABCG2 promoter region contains a large number of CpG islands, suggesting that the expression of ABCG2 is likely regulated by promoter methylation.At present, the study on the ABCG2 gene expression and regulation of methylation is less, especially in chronic myeloid leukemia. Therefore, our research analyzed chronic myeloid leukemia cell line K562 and the Gleevec-resistant chronic myeloid leukemia cell line K562/Glv, then carry out in virto experiments to investigate the relationship between the methylation status of ABCG2 promoter and its expression in cell, which provides a new target to reverse the Gleevec resistance mediated by ABCG2 gene, for the purpose of improving therapeutic effectiveness and improving tumor patients’ life quality.METHODS:①We analyzed K562 and K562/Glv cells, and used SYBR Green based Real-Time PCR and flow cytometry to detect the ABCG2 mRNA and protein expression separately, and used MSP to detect ABCG2 promoter methylation status.②After exposured to the 5-azacytidine(10μmol/l) for 72 hour, we also used SYBR Green based Real-Time PCR and flow cytometry to detect the ABCG2 mRNA and protein expression separately in two cell lines, and used MSP to detect ABCG2 promoter methylation status.RESULT:①ABCG2 mRNA expression in K562/Glv cell was significantly higher than K562 cell (P<0.01); ABCG2 protein expression is low in K562 cell [(1.953±0.252)%] and K562/Glv cell [(1.383±0.259)%]; ABCG2 promoter in K562 and K562/Glv cells is complete methylation.②After exposured to the 5-azacytidine, ABCG2 promoter was completely unmethylated in K562 cell, ABCG2 mRNA and protein expression were significantly higher than before (P<0.01).③After exposured to the 5-azacytidine, ABCG2 promoter was partly non-methylated, ABCG2 mRNA and protein expression were higher than before, but no significant difference (P>0.05). ④After exposured to the 5-azacytidine, ABCG2 promoter methylation status in K562 cell was lower than K562/Glv cell (P<0.05), but ABCG2 mRNA and protein expression in K562 cell were higher than K562/Glv cell (P <0.05).CONCLUSIONS:①ABCG2 expression maybe has a certain relationship with Gleevec resistence in chronic myeloid leukemia, and ABCG2 expression is regulated by promoter methylation at least in partial.②ABCG2 protein expression is correlated with mRNA transcriptional level and the regulation of post-transcription.

Related Dissertations

  1. The Research of the Expression Level of Hexokinasel1 in the Chronic Phase and Blastic Phase of Patients with Chronic Myeloid Leukemia,R733.7
  2. Studies on the Mechanism and Recovery Measures of Hyperhydricity of Pyrus Calleryana Decne in Vitro,S661.2
  3. Molecular Characterization, Expression, and Promoter Methylation Status of the Bovine Synaptonemal Complex Protein 3 Gene,S823
  4. Effects of 5-Aza-2-deoxycytidine on DNA Methylation and Expression of p16 and MGMT Gene in Lung Cancer Cell Line SPC-A-1,R734.2
  5. Methylation of p16 Gene in Plasma and Tissues from Non-small Cell Lung Cancer Patients, Demethylation and the Biological Behavior of Lung Cancer Cell and Transcription of p16 Gene,R734.2
  6. Further Studies on the Side Effects of Imatinib in the Treatment of Patients with GIST,R735
  7. Molecular Diagnosis for Changes of Methylation of MLH1 Promoter of Arabidopsis Thaliana Induced by Cadmium Stress,X173
  8. Effect of SO2 Exposure on DNA Methylation Polymorphism in Arabiadopsis Thaliana,Q943
  9. Effections of Histone Special Sites Methylation Changes on Transcription Functions of Complete and the Second Structure Domain Flaw ELP3,Q75
  10. Structure Biological Studies of Histone Demethylases Jhd2 & JMJD5 and Expression, Purification of Staphylococcus Aureus HssSR,Q93
  11. Synthesis of 4-Hydroxy-2-Pyridones and Demethylation of 4-Methoxy-2-Pyridones,O621.25
  12. Screening of Age-related DNA Methylation Fragments,D919.2
  13. Lead Exposure in SH—SY5Y Cells Influence the mRNA Expression and the Global DNA Methylation,R114
  14. Effects of PBDE-47 on p53 Function and Activation in SH-SY5Y Apoptosis,R114
  15. Mechanism of Methylated CpG Sites of MLH1 Gene in Colorectal Cancer Cells,R735.34
  16. Thyroid cancer blood spectra of DNA methylation,R736.1
  17. Studies on the Effects and Mechanism of TSPYL5 Anti-oncogene on Development and Progress in Gastric Carcinoma,R735.2
  18. Alteration of the Hypomethylation Status of HOXA10 Gene in Epithelial Ovarian Cancer,R737.31
  19. Methylation Change of MiR-203 Gene and Its Significance in Hazakh’s Esophageal Squamous Cell Carcinoma in Xinjiang Province, China,R735.1
  20. Notch1 and Its Ligand of JAG1 Gene Methylation Role of Onset in Mammary Gland Carcinoma and Difference between Uygur and Han Women in XinJiang,R737.9

CLC: > Medicine, health > Oncology > Hematopoietic and lymphoid neoplasms > Leukemia
© 2012 www.DissertationTopic.Net  Mobile